InvestSMART

MGC Pharmaceuticals Ltd (ASX: MXC) - Announcements

Current share price for MXC : $0.420 0.01 (2.44%)+

ASX company news and announcements for MGC Pharmaceuticals Ltd (MXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MGC Pharmaceuticals Ltd (MXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MGC Pharmaceuticals Ltd (MXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MGC Pharmaceuticals Ltd (MXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Trading Halt 30 Nov 2021 9:21AM $0.041 $0.420 risen by 924.39%
$18 Production Completed of A$1M ArtemiC Order from SPC 25 Nov 2021 9:25AM $0.045 $0.420 risen by 833.33%
$18 Results of 2021 Annual General Meeting 25 Nov 2021 8:16AM $0.045 $0.420 risen by 833.33%
$18 Issue of Shares and Convertible Note Maturity Extension 24 Nov 2021 2:15PM $0.044 $0.420 risen by 854.55%
$18 Proposed issue of securities - MXC 24 Nov 2021 2:04PM $0.044 $0.420 risen by 854.55%
$18 Appendix 3Y - Change of Director's Interest Notice 24 Nov 2021 1:39PM $0.045 $0.420 risen by 833.33%
$18 Application for quotation of securities - MXC 24 Nov 2021 1:35PM $0.045 $0.420 risen by 833.33%
$18 Application for quotation of securities - MXC 24 Nov 2021 1:30PM $0.045 $0.420 risen by 833.33%
$18 US Supply and Distribution Agreement Update 23 Nov 2021 9:31AM $0.045 $0.420 risen by 833.33%
$18 AGM Webcast Registration Details 19 Nov 2021 5:36PM $0.046 $0.420 risen by 813.04%
$18 Notice of upcoming release of shares from voluntary escrow 17 Nov 2021 8:19AM $0.048 $0.420 risen by 775%
$18 Section 323DB Jobkeeper Receipts Notice 12 Nov 2021 5:30PM $0.048 $0.420 risen by 775%
$18 Notification regarding unquoted securities - MXC 12 Nov 2021 5:21PM $0.048 $0.420 risen by 775%
$18 MALTA CIMETRA PRODUCTION FACILITY UPDATE 3 Nov 2021 8:14AM $0.047 $0.420 risen by 793.62%
$18 CIMETRA DOSE FINDING STUDY APPROVAL 2 Nov 2021 9:22AM $0.048 $0.420 risen by 775%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 26 Oct 2021 2:20PM $0.050 $0.420 risen by 740%
$18 Annual Report to shareholders 25 Oct 2021 5:53PM $0.050 $0.420 risen by 740%
$18 Letter to Shareholders - Dispatch of 2021 AGM Documents 25 Oct 2021 5:00PM $0.050 $0.420 risen by 740%
$18 Notice of Annual General Meeting/Proxy Form 25 Oct 2021 4:53PM $0.050 $0.420 risen by 740%
$18 Response to ASX Query Letter 15 Oct 2021 2:55PM $0.053 $0.420 risen by 692.45%
$18 Investor Presentation - CimetrA 12 Oct 2021 9:11AM $0.055 $0.420 risen by 663.64%
$18 Correction to Announcement Title - Issue of Shares 7 Oct 2021 7:13PM $0.059 $0.420 risen by 611.86%
$18 s708A(5)(e) Cleansing Notice 7 Oct 2021 5:25PM $0.059 $0.420 risen by 611.86%
$18 Appendix 3Y 7 Oct 2021 4:15PM $0.059 $0.420 risen by 611.86%
$18 Issue of shares and resignation of Company Secretary 7 Oct 2021 4:10PM $0.059 $0.420 risen by 611.86%

251 - 275 of 818 results

Page 11 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.